Molecular Oncology
Volume 1, Issue 1 , Pages 84-96 , June 2007

The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression

  • Paraic A. Kenny

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
    • These authors contributed equally to this report.
  • ,
  • Genee Y. Lee

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
    • These authors contributed equally to this report.
  • ,
  • Connie A. Myers

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
    • Present address: Division of Neuropathology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • ,
  • Richard M. Neve

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Jeremy R. Semeiks

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Paul T. Spellman

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Katrin Lorenz

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
    • Present address: Department of Molecular Medicine, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany.
  • ,
  • Eva H. Lee

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Mary Helen Barcellos-Hoff

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Ole W. Petersen

      Affiliations

    • Structural Cell Biology Unit, Institute of Medical Anatomy, The Panum Institute, University of Copenhagen, DK-2200 Copenhagen N, Denmark
  • ,
  • Joe W. Gray

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
  • ,
  • Mina J. Bissell

      Affiliations

    • Life Sciences Division, Lawrence Berkeley National Laboratory, University of California, One Cyclotron Road, MS 977-225A, Berkeley, CA 94720, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 510 486 4365; Fax: +1 510 486 5586.

Received 31 January 2007 ,Accepted 1 February 2007.

References 

  1. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Research. 1987;47:3239–3245
  2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nature Genetics. 2000;25:25–29
  3. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105:223–235
  4. Bellis SL. Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochimica et Biophysica Acta. 2004;1663:52–60
  5. Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439:353–357
  6. Bissell DM, Hammaker LE, Meyer UA. Parenchymal cells from adult rat liver in nonproliferating monolayer culture. I. Functional studies. Journal of Cell Biology. 1973;59:722–734
  7. Bissell DM, Tilles JG. Morphology and function of cells of human embryonic liver in monolayer culture. Journal of Cell Biology. 1971;50:222–231
  8. Bissell MJ. The differentiated state of normal and malignant cells or how to define a “normal” cell in culture. International Review of Cytology. 1981;70:27–100
  9. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression?. Journal of Theoretical Biology. 1982;99:31–68
  10. Bissell MJ, Kenny PA, Radisky DC. Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: the role of extracellular matrix and its degrading enzymes. Cold Spring Harbor Symposia on Quantitative Biology. 2005;70:343–356
  11. Bissell MJ, Radisky D. Putting tumours in context. Nature Reviews Cancer. 2001;1:46–54
  12. Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Current Opinion in Cell Biology. 2003;15:753–762
  13. Bissell MJ, Weaver VM, Lelievre SA, Wang F, Petersen OW, Schmeichel KL. Tissue structure, nuclear organization, and gene expression in normal and malignant breast. Cancer Research. 1999;59:1757–1763s(Discussion 1763s-1764s)
  14. Briand P, Nielsen KV, Madsen MW, Petersen OW. Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal. Cancer Research. 1996;56:2039–2044
  15. Briand P, Petersen OW, Van Deurs B. A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium. In Vitro Cellular and Developmental Biology. 1987;23:181–188
  16. Chin K, Devries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, et al Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10:529–541
  17. Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell. 2002;111:29–40
  18. Debnath J, Walker SJ, Brugge JS. Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner. Journal of Cell Biology. 2003;163:315–326
  19. Emerman JT, Pitelka DR. Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro. 1977;13:316–328
  20. Filmus J, Pollak MN, Cailleau R, Buick RN. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochemical and Biophysical Research Communications. 1985;128:898–905
  21. Fournier MV, Martin KJ, Kenny PA, Xhaja K, Bosch I, Yaswen P, et al. Gene expression signature in organized and growth-arrested mammary acini predicts good outcome in breast cancer. Cancer Research. 2006;66:7095–7102
  22. Gazdar AF, Kurvari V, Virmani A, Gollahon L, Sakaguchi M, Westerfield M, et al Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. International Journal of Cancer. 1998;78:766–774
  23. Gunawardane RN, Sgroi DC, Wrobel CN, Koh E, Daley GQ, Brugge JS. Novel role for PDEF in epithelial cell migration and invasion. Cancer Research. 2005;65:11572–11580
  24. Hiraguri S, Godfrey T, Nakamura H, Graff J, Collins C, Shayesteh L, et al Mechanisms of inactivation of E-cadherin in breast cancer cell lines. Cancer Research. 1998;58:1972–1977
  25. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. Journal of Cell Biology. 2005;171:1023–1034
  26. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Research. 2003;31:e15
  27. Isakoff SJ, Engelman JA, Irie HY, Luo J, Brachmann SM, Pearline RV, et al. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Research. 2005;65:10992–11000
  28. Kallioniemi OP, Kallioniemi A, Kurisu W, Thor A, Chen LC, Smith HS, et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:5321–5325
  29. Kenny PA, Bissell MJ. Targeting TACE-dependent EGFR ligand shedding in breast cancer. Journal of Clinical Investigation. 2007;117:337–345
  30. Kleinman HK, Martin GR. Matrigel: basement membrane matrix with biological activity. Seminars in Cancer Biology. 2005;15:378–386
  31. Kraus MH, Popescu NC, Amsbaugh SC, King CR. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO Journal. 1987;6:605–610
  32. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Research and Treatment. 2004;83:249–289
  33. Lee GY, Kenny PA, Lee EH, Bissell MJ. 3D culture models of normal and malignant breast epithelial cells. Nature Methods. 2007;4:359–365
  34. Lelievre SA, Weaver VM, Nickerson JA, Larabell CA, Bhaumik A, Petersen OW, et al. Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:14711–14716
  35. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ. Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 1987;84:136–140
  36. Liu H, Radisky DC, Wang F, Bissell MJ. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. Journal of Cell Biology. 2004;164:603–612
  37. Maniotis AJ, Valyi-Nagy K, Karavitis J, Moses J, Boddipali V, Wang Y, et al Chromatin organization measured by AluI restriction enzyme changes with malignancy and is regulated by the extracellular matrix and the cytoskeleton. American Journal of Pathology. 2005;166:1187–1203
  38. Moyret C, Madsen MW, Cooke J, Briand P, Theillet C. Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522. Experimental Cell Research. 1994;215:380–385
  39. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nature Cell Biology. 2001;3:785–792
  40. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006;10:515–527
  41. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. Journal of Biological Chemistry. 1997;272:24735–24738
  42. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC, et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proceedings of the National Academy of Sciences of the United States of America. 2006;103:12405–12410
  43. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Research. 2006;66:1526–1535
  44. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, et al Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:9212–9217
  45. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumors. Nature. 2000;406:747–752
  46. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:9064–9068
  47. Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, et al Genomic signatures to guide the use of chemotherapeutics. Nature Medicine. 2006;12:1294–1300
  48. Reginato MJ, Mills KR, Paulus JK, Lynch DK, Sgroi DC, Debnath J, et al. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nature Cell Biology. 2003;5:733–740
  49. Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proceedings of the National Academy of Sciences of the United States of America. 1994;91:12378–12382
  50. Roskelley CD, Srebrow A, Bissell MJ. A hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Current Opinion in Cell Biology. 1995;7:736–747
  51. Schmeichel KL, Bissell MJ. Modeling tissue-specific signaling and organ function in three dimensions. Journal of Cell Science. 2003;116:2377–2388
  52. Schmidhauser C, Casperson GF, Myers CA, Sanzo KT, Bolten S, Bissell MJ. A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression. Molecular Biology of the Cell. 1992;3:699–709
  53. Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell–cell interaction and morphological polarity. Journal of Cell Biology. 1991;115:1383–1395
  54. Streuli CH, Bissell MJ. Expression of extracellular matrix components is regulated by substratum. Journal of Cell Biology. 1990;110:1405–1415
  55. Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, et al. Laminin mediates tissue-specific gene expression in mammary epithelia. Journal of Cell Biology. 1995;129:591–603
  56. van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, Hollestelle A, et al. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. Cancer Research. 2001;61:278–284
  57. Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Petersen OW, et al. Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. Journal of the National Cancer Institute. 2002;94:1494–1503
  58. Wang F, Weaver VM, Petersen OW, Larabell CA, Dedhar S, Briand P, et al. Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:14821–14826
  59. Weaver VM, Lelievre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, et al. Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell. 2002;2:205–216
  60. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, et al. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. Journal of Cell Biology. 1997;137:231–245
  61. Wrobel CN, Debnath J, Lin E, Beausoleil S, Roussel MF, Brugge JS. Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. Journal of Cell Biology. 2004;165:263–273
  62. Xu, R., Spencer, V.A., Bissell, M.J., 2007. Extracellular matrix-regulated gene expression requires cooperation of SWI/SNF and transcription factors. Journal of Biological Chemistry, in press.
  63. Zhan L, Xiang B, Muthuswamy SK. Controlled activation of ErbB1/ErbB2 heterodimers promote invasion of three-dimensional organized epithelia in an ErbB1-dependent manner: implications for progression of ErbB2-overexpressing tumors. Cancer Research. 2006;66:5201–5208

PII: S1574-7891(07)00007-5

doi: 10.1016/j.molonc.2007.02.004

Molecular Oncology
Volume 1, Issue 1 , Pages 84-96 , June 2007